The document appears to be a survey collecting information from medical professionals about the countries they practice in, their gender and age, the number of various types of cancer patients they see annually or monthly, and their preferred treatment approaches for multiple myeloma and the goals of that treatment. It asks respondents to select from given options for each question.

1. What country do you practice in?
1. Thailand
2.India
3.China
4. S. Korea
5. Other

2. Your gender is?
1.Male
2. Female

3. Your Age is?
1. 20-40
2. 40-60
3. >60

4. How many new MDS patients do
you see each year?
1. Less than 5
2. 5 - 10
3. 11 - 15
4.More than 15

5. How many new Multiple Myeloma
patients do you see each year?
1. Less than 5
2. 5 - 10
3. 11 - 15
4.More than 15

6. How many new CLL patients do
you see each year?
1. Less than 5
2. 5 - 10
3. 11 - 15
4.More than 15

7. How many new NHL patients do
you see each year?
1. Less than 5
2. 5 - 10
3. 11 - 15
4. >15

8. How many new CML patients do
you see each month?
1. Less than 5
2. 5 - 10
3. 11 - 15
4. >15

9. How many new Aplastic Anemia
patients do you see each month?
1. Less than 5
2. 5 - 10
3. 11 - 15
4. >15

10. What is your preferred induction
for newly diagnosed MM?
A.Bortezomib /Dex
B.Lenalidomide /Dex
C.Bortezomib /Thal/ Dex
D.Bortezomib /Len/Dex
E.Other

11. What is your goal of treatment
for newly diagnosed MM?
A.Disease control
B.Curative approach (Maximize the
CR depth)